-
Autobio Diagnostics Partners with MBL to Advance Microbial Mass Spectrometry Technology
•
Autobio Diagnostics Co., Ltd (SHA: 603658), a prominent player in China’s in vitro diagnostic market, has announced a strategic partnership with Japan’s Medical & Biological Laboratories (MBL). This collaboration will focus on advancing technologies in the microbial mass spectrometer field, although specific financial details of the agreement have not been…
-
Autobio Diagnostics and China National Medical Device Form Strategic Partnership
•
Autobio Diagnostics Co., Ltd (SHA: 603658), a Chinese in-vitro diagnostics company, has entered into a partnership with China National Medical Device Co., Ltd, another domestic firm. The collaboration aims to capitalize on the strengths of both parties to jointly promote and apply high-quality domestic products, thereby expanding the scale of…
-
Autobio Diagnostics Expands Strategic Partnership with Guorun Medical Supply Chain Services
•
China-based Autobio Diagnostics Co., Ltd (SHA: 603658) has announced a strategic partnership with Guorun Medical Supply Chain Services (Shanghai) Co., Ltd, along with 11 shareholding companies. This collaboration aims to enhance the procurement and distribution of in vitro diagnostic (IVD) products and services, ensuring a robust supply chain and fostering…
